Diversified Royalty Corp. (BEVFF)

Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	401	336	297	311	273	226
Market Cap Growth	-7.09%	13.19%	-4.61%	14.16%	20.71%	-14.68%
Enterprise Value	576	506	444	426	402	342
Last Close Price	2.38	1.93	1.80	1.75	1.65	1.26
PE Ratio	21.28	18.16	12.36	27.06	14.67	-
PS Ratio	8.80	7.44	6.94	9.32	9.25	9.43
PB Ratio	2.00	1.67	1.65	1.80	1.80	1.52
P/FCF Ratio	12.60	10.40	12.72	14.84	12.51	13.02
P/OCF Ratio	12.59	10.40	12.72	14.84	12.40	13.02
EV/Sales Ratio	12.13	11.20	10.39	12.76	13.65	14.30
EV/EBITDA Ratio	13.47	12.45	11.55	14.26	15.33	-
EV/EBIT Ratio	13.49	12.47	11.57	14.30	15.37	16.41
EV/FCF Ratio	18.09	15.67	19.05	20.32	18.45	19.74
Debt / Equity Ratio	0.89	0.90	1.29	0.86	0.89	0.84
Debt / EBITDA Ratio	4.35	4.46	6.01	4.95	5.13	-
Debt / FCF Ratio	5.60	5.61	9.92	7.06	6.19	7.17
Asset Turnover	0.12	0.11	0.11	0.11	0.10	0.09
Quick Ratio	1.75	4.55	0.67	2.20	0.23	3.68
Current Ratio	1.76	4.57	0.69	2.26	0.23	3.77
Return on Equity (ROE)	9.38%	10.12%	13.46%	7.32%	12.34%	-4.70%
Return on Assets (ROA)	6.44%	6.37%	6.18%	6.01%	5.60%	4.72%
Return on Capital (ROIC)	6.77%	6.68%	6.49%	6.33%	5.83%	4.90%
Return on Capital Employed (ROCE)	10.50%	10.20%	9.20%	8.90%	10.40%	7.50%
Earnings Yield	4.70%	5.51%	8.09%	3.69%	6.82%	-3.09%
FCF Yield	7.94%	9.62%	7.86%	6.74%	7.99%	7.68%
Dividend Yield	7.60%	8.97%	10.12%	9.43%	9.88%	12.90%
Payout Ratio	132.30%	130.82%	94.86%	157.43%	94.03%	-
Buyback Yield / Dilution	-14.06%	-13.61%	-13.57%	6.43%	-14.05%	-8.57%
Total Shareholder Return	-6.46%	-4.63%	-3.45%	15.86%	-4.17%	4.33%

Updated Nov 6, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.